Tatsuaki Takeda

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in <i>EGFR</i> -Mutant Non–Small Cell Lung Cancer Cells

Kei Namba, Kazuhiko Shien, Yuta Takahashi et al. · Molecular Cancer Research · 2018 · 93 citations · Full text

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki et al. · PLoS ONE · 2017 · 41 citations · Full text

Acquired resistance mechanisms to afatinib in <i><scp>HER</scp>2</i>‐amplified gastric cancer cells

Takahiro Yoshioka, Kazuhiko Shien, Tatsuaki Takeda et al. · Cancer Science · 2019 · 37 citations · Full text

Therapeutic strategies for afatinib‐resistant lung cancer harboring <i><scp>HER</scp>2</i> alterations

Hidejiro Torigoe, Kazuhiko Shien, Tatsuaki Takeda et al. · Cancer Science · 2018 · 25 citations · Full text

YES1 activation induces acquired resistance to neratinib in <i>HER2</i>‐amplified breast and lung cancers

Tatsuaki Takeda, Hiromasa Yamamoto, Ken Suzawa et al. · Cancer Science · 2019 · 23 citations · Full text